Tarsus Pharmaceuticals (TARS) Raw Materials (2023 - 2024)
Tarsus Pharmaceuticals (TARS) recorded quarterly Raw Materials of $2.5 million in Q1 2024, little changed quarter-over-quarter from $2.5 million in Q4 2023.
Tarsus Pharmaceuticals (TARS) Raw Materials (2023 - 2024) Analysis & Trends
Tarsus Pharmaceuticals' Raw Materials history runs 2 years deep, the most recent figure standing at $2.5 million for Q1 2024.
- In Q1 2024, Raw Materials changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2024 stood at $2.5 million (changed N/A YoY), while the FY2023 annual figure was $2.5 million, changed N/A from the prior year.
- Raw Materials was $2.5 million for Q1 2024 at Tarsus Pharmaceuticals, roughly flat from $2.5 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $2.5 million in Q4 2023 to a low of $2.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tarsus Pharmaceuticals | 2.71 Bn | 2.61 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 2.53 Mn |